CompaniesEyevance Pharmaceuticals

Eyevance Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (13)
View all

Total Trials

13

As Lead Sponsor

13

As Collaborator

0

Total Enrollment

1,432

By Phase

NA: 2PHASE2: 4PHASE1: 2PHASE3: 3PHASE1/PHASE2: 2

By Status

COMPLETED: 12TERMINATED: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
NCT02517619
Hover over trial bars to see details

Recent Trials

NCT03938883Lead Sponsor
"Ocular Bandage Gel (OBG) Pivotal Trial in Patients Undergoing Photorefractive Keratectomy (PRK)"
NACompleted
250 participants
Started: Jun 25, 2019 · Completed: Oct 10, 2019
NCT03163641Lead Sponsor
Safety and Effectiveness of OBG vs.a Bandage Contact Lens for Large Corneal Epithelial Defects in Patients Post-PRK.
NACompleted
45 participants
Started: Aug 5, 2018 · Completed: Nov 8, 2018
NCT03180255Lead Sponsor
Iontophoretic Delivery of EGP-437 in Patients Who Have Undergone Cataract Surgery
PHASE2Completed
101 participants
Started: Jul 26, 2017 · Completed: Nov 27, 2017
NCT02644694Lead Sponsor
PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy
PHASE1Completed
10 participants
Started: Mar 31, 2016 · Completed: Nov 30, 2016
NCT02517619Lead Sponsor
Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis
PHASE3Completed
251 participants
Started: Jan 16, 2016 · Completed: May 29, 2018
View all 13 trials →
Related Companies
Santen
acquired
Eyevance Pharmaceuticals | Biotech Hunter | Biotech Hunter